DOCSLIB.ORG

Final List Entrezgene 507

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Final List Entrezgene 507 Supplemental Table 1. Final List_Entrezgene_507 EntrezGene ID Gene Name 1 Alpha-1-B glycoprotein 60 Actin, beta 86 Actin-like 6A 109 Adenylate cyclase 3 191 S-adenosylhomocysteine hydrolase 291 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 302 Annexin A2 488 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 506 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 558 AXL receptor tyrosine kinase 629 B-factor, properdin 645 Biliverdin reductase B (flavin reductase (NADPH)) 648 Polycomb group ring finger 4 805 Calmodulin 2 (phosphorylase kinase, delta) 808 Calmodulin 3 (phosphorylase kinase, delta) 871 Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) 960 CD44 antigen (homing function and Indian blood group system) 978 Cytidine deaminase 1063 Centromere protein F, 350/400ka (mitosin) 1117 Chitinase 3-like 2 1213 Clathrin, heavy polypeptide (Hc) 1385 CAMP responsive element binding protein 1 1399 V-crk sarcoma virus CT10 oncogene homolog (avian)-like 1431 Citrate synthase 1591 Cytochrome P450, family 24, subfamily A, polypeptide 1 1627 Drebrin 1 1675 D component of complement (adipsin) 1716 Deoxyguanosine kinase 1718 24-dehydrocholesterol reductase Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate 1738 complex, branched chain keto acid dehydrogenase complex) 1777 Deoxyribonuclease II, lysosomal 1836 Solute carrier family 26 (sulfate transporter), member 2 1915 Eukaryotic translation elongation factor 1 alpha 1 1937 Eukaryotic translation elongation factor 1 gamma 1938 Eukaryotic translation elongation factor 2 1968 Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa 1984 Eukaryotic translation initiation factor 5A 2023 Enolase 1, (alpha) 2079 Enhancer of rudimentary homolog (Drosophila) 2091 Fibrillarin 2152 Coagulation factor III (thromboplastin, tissue factor) 2175 Fanconi anemia, complementation group A 2218 Fukuyama type congenital muscular dystrophy (fukutin) 2261 Fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) 2314 Flightless I homolog (Drosophila) 2495 Ferritin, heavy polypeptide 1 2512 Ferritin, light polypeptide 2547 X-ray repair complementing defective repair in Chinese hamster cells 6 (Ku autoantigen, 70kDa) 2582 UDP-galactose-4-epimerase 2734 Golgi apparatus protein 1 2739 Glyoxalase I 2760 GM2 ganglioside activator 2778 GNAS complex locus 2828 G protein-coupled receptor 4 2896 Granulin 2909 Glucocorticoid receptor DNA binding factor 1 2947 Glutathione S-transferase M3 (brain) 3054 Host cell factor C1 (VP16-accessory protein) 3065 Histone deacetylase 1 3074 Hexosaminidase B (beta polypeptide) 3146 High-mobility group box 1 3159 High mobility group AT-hook 1 3229 Nucleoporin 98kDa 3275 HMT1 hnRNP methyltransferase-like 1 (S. cerevisiae) 3301 DnaJ (Hsp40) homolog, subfamily A, member 1 3320 Heat shock 90kDa protein 1, alpha 3326 Heat shock 90kDa protein 1, beta 3339 Heparan sulfate proteoglycan 2 (perlecan) 3340 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 3371 Tenascin C (hexabrachion) 3383 Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 3454 Interferon (alpha, beta and omega) receptor 1 3486 Insulin-like growth factor binding protein 3 3551 Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 3569 Interleukin 6 (interferon, beta 2) 3609 Interleukin enhancer binding factor 3, 90kDa 3688 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 3767 Potassium inwardly-rectifying channel, subfamily J, member 11 3799 Kinesin family member 5B 3838 Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) 3856 Keratin 8 3897 L1 cell adhesion molecule 3949 Low density lipoprotein receptor (familial hypercholesterolemia) 3996 Lethal giant larvae homolog 1 (Drosophila) 4012 Leucyl/cystinyl aminopeptidase 4017 Lysyl oxidase-like 2 4048 Leukotriene A4 hydrolase 4087 SMAD, mothers against DPP homolog 2 (Drosophila) 4088 SMAD, mothers against DPP homolog 3 (Drosophila) 4144 Methionine adenosyltransferase II, alpha 4162 Melanoma cell adhesion molecule 4174 MCM5 minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) 4241 Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 4247 Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 4324 Matrix metallopeptidase 15 (membrane-inserted) 4507 Methylthioadenosine phosphorylase 4673 60S ribosomal protein L6 (RPL6A) 4712 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa 4720 NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) 4779 Nuclear factor (erythroid-derived 2)-like 1 4809 NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) 4898 Nardilysin (N-arginine dibasic convertase) 4904 Y box binding protein 1 4927 Nucleoporin 88kDa 4928 Nucleoporin 98kDa 4967 Oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) 5054 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 5170 3-phosphoinositide dependent protein kinase-1 5465 Peroxisome proliferative activated receptor, alpha 5499 Protein phosphatase 1, catalytic subunit, alpha isoform 5510 Protein phosphatase 1, regulatory subunit 7 5529 Protein phosphatase 2, regulatory subunit B (B56), epsilon isoform 5581 Protein kinase C, epsilon 5631 Phosphoribosyl pyrophosphate synthetase 1 5683 Proteasome (prosome, macropain) subunit, alpha type, 2 5719 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 5770 Protein tyrosine phosphatase, non-receptor type 1 5806 Pentraxin-related gene, rapidly induced by IL-1 beta 5932 Retinoblastoma binding protein 8 5933 Retinoblastoma-like 1 (p107) 5935 RNA binding motif (RNP1, RRM) protein 3 6044 Ribosomal protein SA 6059 ATP-binding cassette, sub-family E (OABP), member 1 6118 Replication protein A2, 32kDa 6128 Ribosomal protein L6 6129 Ribosomal protein L7 6132 Ribosomal protein L8 6138 Ribosomal protein L15 6142 Ribosomal protein L18a 6155 Ribosomal protein L27 6171 Ribosomal protein L41 6201 Ribosomal protein S7 6202 Ribosomal protein S8 6229 Ribosomal protein S24 6235 Ribosomal protein S29 6303 Spermidine/spermine N1-acetyltransferase 6352 Chemokine (C-C motif) ligand 5 6397 SEC14-like 1 (S. cerevisiae) 6400 Sel-1 suppressor of lin-12-like (C. elegans) 6633 Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa 6647 Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) 6726 Signal recognition particle 9kDa 6728 Signal recognition particle 19kDa 6744 Sperm specific antigen 2 6749 Structure specific recognition protein 1 6774 Signal transducer and activator of transcription 3 (acute-phase response factor) 6776 Signal transducer and activator of transcription 5A 6777 Signal transducer and activator of transcription 5B 6790 Serine/threonine kinase 6 6868 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 6873 TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa 6904 Tubulin-specific chaperone d 7024 Transcription factor CP2 7035 Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) 7045 Transforming growth factor, beta-induced, 68kDa 7088 Transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) 7095 Translocation protein 1 7184 Tumor rejection antigen (gp96) 1 7277 Tubulin, alpha 1 (testis specific) 7290 HIR histone cell cycle regulation defective homolog A (S. cerevisiae) 7316 Ubiquitin C 7342 Upstream binding protein 1 (LBP-1a) 7464 Coronin, actin binding protein, 2A 7490 Wilms tumor 1 7574 Zinc finger protein 26 (KOX 20) 7586 Zinc finger with KRAB and SCAN domains 1 7739 Zinc finger protein 185 (LIM domain) 7846 Tubulin, alpha 3 7922 Solute carrier family 39 (zinc transporter), member 7 8027 Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 8073 Protein tyrosine phosphatase type IVA, member 2 8175 Splicing factor 3a, subunit 2, 66kDa 8237 Ubiquitin specific peptidase 11 8394 Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha 8434 Reversion-inducing-cysteine-rich protein with kazal motifs 8476 CDC42 binding protein kinase alpha (DMPK-like) 8562 Density-regulated protein 8615 Vesicle docking protein p115 8629 Jerky homolog (mouse) 8682 Phosphoprotein enriched in astrocytes 15 8720 Membrane-bound transcription factor peptidase, site 1 8731 RNA (guanine-7-) methyltransferase 8754 ADAM metallopeptidase domain 9 (meltrin gamma) 8864 Period homolog 2 (Drosophila) 8883 Amyloid beta precursor protein binding protein 1 8899 PRP4 pre-mRNA processing factor 4 homolog B (yeast) 8934 RAB7, member RAS oncogene family-like 1 8943 Adaptor-related protein complex 3, delta 1 subunit 9135 Rabaptin, RAB GTPase binding effector protein 1 9144 Synaptogyrin 2 9146 Hepatocyte growth factor-regulated tyrosine kinase substrate 9175 Mitogen-activated protein kinase kinase kinase 13 9191 Death effector domain containing 9202 Zinc finger protein 262 9289 G protein-coupled receptor 56 9334 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 9375 Transmembrane 9 superfamily member 2 9411 Rho GTPase activating protein 29 9416 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 9459 Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 9497 Solute carrier family 4, sodium bicarbonate cotransporter, member 7 9527 Golgi SNAP receptor complex member 1 9529 BCL2-associated athanogene 5 9556 Chromosome 14 open reading frame 2 9564 Breast
Load more

Recommended publications
  • C8cc08685k1.Pdf
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2018 Supporting Information Minimalist Linkers Suitable for Irreversible Inhibitors in Simultaneous Proteome Profiling, Live-Cell Imaging and Drug Screening Cuiping Guo,Yu Chang, Xin Wang, Chengqian Zhang, Piliang Hao*, Ke Ding and Zhengqiu Li* School of Pharmacy, Jinan University, Guangzhou, China 510632 *Corresponding author ([email protected]) 1. General Information All chemicals were purchased from commercial vendors and used without further purification, unless indicated otherwise. All reactions requiring anhydrous conditions were carried out under argon or nitrogen atmosphere using oven-dried glassware. AR-grade solvents were used for all reactions. Reaction progress was monitored by TLC on pre-coated silica plates (Merck 60 F254 nm, 0.25 µm) and spots were visualized by UV, iodine or other suitable stains. Flash column chromatography was carried out using silica gel (Qingdao Ocean). All NMR spectra (1H-NMR, 13C-NMR) were recorded on Bruker 300 MHz/400 MHz NMR spectrometers. Chemical shifts were reported in parts per million (ppm) referenced with respect to appropriate internal standards or residual solvent peaks (CDCl3 = 7.26 ppm, DMSO-d6 = 2.50 ppm). The following abbreviations were used in reporting spectra, br s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublets). Mass spectra were obtained on Agilent LC-ESI-MS system. All analytical HPLC were carried out on Agilent system. Water with 0.1% TFA and acetonitrile with 0.1% TFA were used as eluents and the flow rate was 0.5 mL/min.
    [Show full text]
  • The Rise and Fall of the Bovine Corpus Luteum
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
    [Show full text]
  • Reprogramming of Trna Modifications Controls the Oxidative Stress Response by Codon-Biased Translation of Proteins
    Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chan, Clement T.Y. et al. “Reprogramming of tRNA Modifications Controls the Oxidative Stress Response by Codon-biased Translation of Proteins.” Nature Communications 3 (2012): 937. As Published http://dx.doi.org/10.1038/ncomms1938 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/76775 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins Clement T.Y. Chan,1,2 Yan Ling Joy Pang,1 Wenjun Deng,1 I. Ramesh Babu,1 Madhu Dyavaiah,3 Thomas J. Begley3 and Peter C. Dedon1,4* 1Department of Biological Engineering, 2Department of Chemistry and 4Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; 3College of Nanoscale Science and Engineering, University at Albany, SUNY, Albany, NY 12203 * Corresponding author: PCD, Department of Biological Engineering, NE47-277, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; tel 617-253-8017; fax 617-324-7554; email [email protected] 2 ABSTRACT Selective translation of survival proteins is an important facet of cellular stress response. We recently demonstrated that this translational control involves a stress-specific reprogramming of modified ribonucleosides in tRNA.
    [Show full text]
  • Evolution of Translation EF-Tu: Trna
    University of Illinois at Urbana-Champaign Luthey-Schulten Group NIH Resource for Macromolecular Modeling and Bioinformatics Computational Biophysics Workshop Evolution of Translation EF-Tu: tRNA VMD Developer: John Stone MultiSeq Developers Tutorial Authors Elijah Roberts Ke Chen John Eargle John Eargle Dan Wright Zhaleh Ghaemi Jonathan Lai Zan Luthey-Schulten August 2014 A current version of this tutorial is available at http://www.scs.illinois.edu/~schulten/tutorials/ef-tu CONTENTS 2 Contents 1 Introduction 3 1.1 The Elongation Factor Tu . 3 1.2 Getting Started . 4 1.2.1 Requirements . 4 1.2.2 Copying the tutorial files . 4 1.2.3 Working directory . 4 1.2.4 Preferences . 4 1.3 Configuring BLAST for MultiSeq . 5 2 Comparative Analysis of EF-Tu 5 2.1 Finding archaeal EF1A sequences . 6 2.2 Aligning archaeal sequences and removing redundancy . 8 2.3 Finding bacteria EF-Tu sequences . 11 2.4 Performing ClustalW Multiple Sequence and Profile-Profile Align- ments . 12 2.5 Creating Multiple Sequence with MAFFT . 16 2.6 Conservation of EF-Tu among the Bacteria . 16 2.7 Finding conserved residues across the bacterial and archaeal do- mains . 20 2.8 EF-Tu Interface with the Ribosome . 21 3 Computing a Maximum Likelihood Phylogenetic Tree with RAxML 23 3.1 Load the Phylogenetic Tree into MultiSeq . 25 3.2 Reroot and Manipulate the Phylogenetic Tree . 25 4 MultiSeq TCL Scripting: Genomic Context 27 5 Appendix A 30 5.1 Building a BLAST Database . 30 6 Appendix B 31 6.1 Saving QR subset of alignments in PHYLIP and FASTA format 31 6.2 Calculating Maximum Likelihood Trees with RAxML .
    [Show full text]
  • Protein Name Accession Number Molecular Weight Myovi-GTD
    MyoVI-GTD MyoVI-GTD MyoVa-MGT MyoVa-MGT Molecular Spectral Unique Spectral Unique Protein Name Accession Number Weight Counts Peptides Counts Peptides Dync1h1 Cytoplasmic dynein 1 heavy chain 1 IPI00119876 532 kDa 310 121 515 182 Spna2 Spectrin alpha 2 IPI00757353 285 kDa 853 170 597 149 Myo5a 215 kDa protein IPI00875222 215 kDa 162 47 874 109 AU042671 hypothetical protein LOC269700 isoform 1 IPI00762814 453 kDa 2 2 231 104 Spnb2 Isoform 1 of Spectrin beta chain, brain 1 IPI00319830 274 kDa 505 122 347 100 Dmxl2 Isoform 1 of DmX-like protein 2 IPI00853932 338 kDa 63 38 251 100 Cltc Clathrin heavy chain 1 IPI00169916 (+1) 192 kDa 1994 138 565 90 Mtap2 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530026F16 product:microtubule-associated protein 2, full insert sequenceIPI00894724 199 kDa 229 82 258 74 Mtap1a Isoform 1 of Microtubule-associated protein 1A IPI00408909 (+1) 300 kDa 310 86 214 74 Itpr1 Isoform 4 of Inositol 1,4,5-trisphosphate receptor type 1 IPI00230019 (+3) 311 kDa 37 18 155 73 Huwe1 HECT, UBA and WWE domain containing 1 IPI00463909 (+1) 483 kDa 5 5 91 69 Fasn Fatty acid synthase IPI00113223 272 kDa 24 17 140 68 Usp9x Ubiquitin carboxyl-terminal hydrolase IPI00798468 291 kDa 68 45 98 65 Lrp1 Prolow-density lipoprotein receptor-related protein 1 precursor IPI00119063 505 kDa 92 53 109 62 Myh10 Myosin-10 IPI00515398 (+1) 229 kDa 65 40 98 59 Mical1 NEDD9-interacting protein with calponin homology and LIM domains IPI00116371 117 kDa 2 2 203 57 Plec1 Isoform PLEC-1I of Plectin-1 IPI00229509 (+10)
    [Show full text]
  • Allele-Specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish
    Allele-specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish by Ailu Chen A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama August 1, 2015 Keywords: catfish, interspecific hybrids, allele-specific expression, ribosomal protein Copyright 2015 by Ailu Chen Approved by Zhanjiang Liu, Chair, Professor, School of Fisheries, Aquaculture and Aquatic Sciences Nannan Liu, Professor, Entomology and Plant Pathology Eric Peatman, Associate Professor, School of Fisheries, Aquaculture and Aquatic Sciences Aaron M. Rashotte, Associate Professor, Biological Sciences Abstract Interspecific hybridization results in a vast reservoir of allelic variations, which may potentially contribute to phenotypical enhancement in the hybrids. Whether the allelic variations are related to the downstream phenotypic differences of interspecific hybrid is still an open question. The recently developed genome-wide allele-specific approaches that harness high- throughput sequencing technology allow direct quantification of allelic variations and gene expression patterns. In this work, I investigated allele-specific expression (ASE) pattern using RNA-Seq datasets generated from interspecific catfish hybrids. The objective of the study is to determine the ASE genes and pathways in which they are involved. Specifically, my study investigated ASE-SNPs, ASE-genes, parent-of-origins of ASE allele and how ASE would possibly contribute to heterosis. My data showed that ASE was operating in the interspecific catfish system. Of the 66,251 and 177,841 SNPs identified from the datasets of the liver and gill, 5,420 (8.2%) and 13,390 (7.5%) SNPs were identified as significant ASE-SNPs, respectively.
    [Show full text]
  • Allosteric Collaboration Between Elongation Factor G and the Ribosomal L1 Stalk Directs Trna Movements During Translation
    Allosteric collaboration between elongation factor G and the ribosomal L1 stalk directs tRNA movements during translation Jingyi Feia, Jonathan E. Bronsona, Jake M. Hofmanb,1, Rathi L. Srinivasc, Chris H. Wigginsd and Ruben L. Gonzalez, Jr.a,2 aDepartment of Chemistry, bDepartment of Physics, cThe Fu Foundation School of Engineering and Applied Science and dDepartment of Applied Physics and Applied Mathematics, Columbia University, New York, NY 10027 1Current address: Yahoo! Research, 111 West 40th Street, 17th Floor, NewYork, NY 10018 2To whom correspondence may be addressed. E-mail: [email protected] Classification: Biological Sciences, Biochemistry ABSTRACT Determining the mechanism by which transfer RNAs (tRNAs) rapidly and precisely transit through the ribosomal A, P and E sites during translation remains a major goal in the study of protein synthesis. Here, we report the real-time dynamics of the L1 stalk, a structural element of the large ribosomal subunit that is implicated in directing tRNA movements during translation. Within pre-translocation ribosomal complexes, the L1 stalk exists in a dynamic equilibrium between open and closed conformations. Binding of elongation factor G (EF-G) shifts this equilibrium towards the closed conformation through one of at least two distinct kinetic mechanisms, where the identity of the P-site tRNA dictates the kinetic route that is taken. Within post-translocation complexes, L1 stalk dynamics are dependent on the presence and identity of the E-site tRNA. Collectively, our data demonstrate that EF-G and the L1 stalk allosterically collaborate to direct tRNA translocation from the P to the E sites, and suggest a model for the release of E-site tRNA.
    [Show full text]
  • Attenuation of Ganglioside GM1 Accumulation in the Brain of GM1 Gangliosidosis Mice by Neonatal Intravenous Gene Transfer
    Gene Therapy (2003) 10, 1487–1493 & 2003 Nature Publishing Group All rights reserved 0969-7128/03 $25.00 www.nature.com/gt RESEARCH ARTICLE Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer N Takaura1, T Yagi2, M Maeda2, E Nanba3, A Oshima4, Y Suzuki5, T Yamano1 and A Tanaka1 1Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan; 2Department of Neurobiology and Anatomy, Osaka City University Graduate School of Medicine, Osaka, Japan; 3Gene Research Center, Tottori University, Yonago, Japan; 4Department of Pediatrics, Takagi Hospital, Saitama, Japan; and 5Pediatrics, Clinical Research Center, Nasu Institute for Developmental Disabilities, International University of Health and Welfare, Ohtawara, Japan A single intravenous injection with 4 Â 107 PFU of recombi- ganglioside GM1 was above the normal range in all treated nant adenovirus encoding mouse b-galactosidase cDNA to mice, which was speculated to be the result of reaccumula- newborn mice provided widespread increases of b-galacto- tion. However, the values were still definitely lower in most of sidase activity, and attenuated the development of the the treated mice than those in untreated mice. In the disease including the brain at least for 60 days. The b- histopathological study, X-gal-positive cells, which showed galactosidase activity showed 2–4 times as high a normal the expression of exogenous b-galactosidase gene, were activity in the liver and lung, and 50 times in the heart. In the observed in the brain. It is noteworthy that neonatal brain, while the activity was only 10–20% of normal, the administration via blood vessels provided access to the efficacy of the treatment was distinct.
    [Show full text]
  • Improvement of Spontaneous Alternation Behavior Deficit by Activation Ofα4β2 Nicotinic Acetylcholine Receptor Signaling in the Ganglioside GM3-Deficient Mice
    Biomedical Research 34 (4) 189-195, 2013 Improvement of spontaneous alternation behavior deficit by activation of α4β2 nicotinic acetylcholine receptor signaling in the ganglioside GM3- deficient mice 1 1 2 1 2 1 Kimie NIIMI , Chieko NISHIOKA , Tomomi MIYAMOTO , Eiki TAKAHASHI , Ichiro MIYOSHI , Chitoshi ITAKURA , 3, 4 and Tadashi YAMASHITA 1 Riken Brain Science Institute, Saitama 351-0198, Japan; 2 Graduate School of Medical Sciences, Nagoya City University, Nagoya 467- 8601, Japan; 3 Graduate School of Veterinary Medicine, Azabu University, Sagamihara 252-5201, Japan; and 4 World Class University Program, Kyungpook National University School of Medicine, Daegu, South Korea (Received 13 May 2013; and accepted 17 June 2013) ABSTRACT We have reported that in ganglioside GM3-deficient (GM3−/−) mice, spontaneous alternation be- havior assessed by a Y-maze task was significantly lower, and total arm entries were significantly higher than in wild-type mice. The objective of the present study was to examine the role of nico- tinic acetylcholine receptor (nAChR) signaling in impairment of spontaneous alternation behavior of GM3−/− mice. Nicotine treatment (0.3, 1.0 mg/kg, s.c.) dose dependently improved the sponta- neous alternation deficit without affecting total arm entries in GM3−/− mice. The nicotine-induced (1.0 mg/kg, s.c.) improvement was significantly abolished by the nAChR antagonist mecamyla- mine (1.0 mg/kg, i.p.). The α4β2 nAChR antagonist dihydro-β-erythroidine (2.5, 10.0 mg/kg, i.p.) dose dependently counteracted the nicotine-induced improvement of spontaneous alternation in GM3−/− mice, whereas the α7 nAChR antagonist methyllycaconitine (2.5, 10.0 mg/kg, i.p.) did not.
    [Show full text]
  • Eef2k) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy
    International Journal of Molecular Sciences Review Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy Bin Zhang 1 , Jiamei Zou 1, Qiting Zhang 2, Ze Wang 1, Ning Wang 2,* , Shan He 1 , Yufen Zhao 2 and C. Benjamin Naman 1,* 1 Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, College of Food and Pharmaceutical Sciences, Ningbo University, Ningbo 315800, China; [email protected] (B.Z.); [email protected] (J.Z.); [email protected] (Z.W.); [email protected] (S.H.) 2 Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China; [email protected] (Q.Z.); [email protected] (Y.Z.) * Correspondence: [email protected] (N.W.); [email protected] (C.B.N.) Abstract: Eukaryotic elongation factor 2 kinase (eEF2K or Ca2+/calmodulin-dependent protein kinase, CAMKIII) is a new member of an atypical α-kinase family different from conventional protein kinases that is now considered as a potential target for the treatment of cancer. This protein regulates the phosphorylation of eukaryotic elongation factor 2 (eEF2) to restrain activity and inhibit the elongation stage of protein synthesis. Mounting evidence shows that eEF2K regulates the cell cycle, autophagy, apoptosis, angiogenesis, invasion, and metastasis in several types of cancers. The Citation: Zhang, B.; Zou, J.; Zhang, expression of eEF2K promotes survival of cancer cells, and the level of this protein is increased in Q.; Wang, Z.; Wang, N.; He, S.; Zhao, many cancer cells to adapt them to the microenvironment conditions including hypoxia, nutrient Y.; Naman, C.B.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Profilin-1 Is Required for Survival of Adult Hematopoietic Stem Cells
    Extended methods Immunohistochemistry HepG-2, SMMC-7721, and 293T cells were obtained from Cell Resource Center of Shanghai Institute for Biological Science, Chinese Academy Science, Shanghai, China. HUVEC cells were kindly provided by Prof. Ping-Jin Gao at Institute of Health Sciences (Shanghai, China). All these cell lines were cultured in DMEM with 10% FBS. MDA- MB-231 cell line was kindly provided by Prof. Ming-Yao Liu (East China Normal University, Shanghai, China) and was cultured in Leibovitz L-15 medium with 10% FBS. All these cell lines were originally purchased from ATCC. MDA-MB-231, SMMC-7721 or HepG2 cells were grown on coverslips in 24-well plates and fixed in either 4% paraformaldehyde or pre-chilled methanol (-20°C) for 10 min. In some cases, WT or VPS33B-null Lin-Sca-1+c-Kit+Flk2-CD34- LT-HSCs were collected by flow cytometry and fixed for immunofluorescence staining. Cells were then blocked with 3% BSA in PBS for 60 min followed by incubation with primary antibodies overnight. The antibodies used were anti-HA (Sigma), anti-Flag (Sigma), anti-VPS33B (Sigma), anti- VPS16B (Abcam), anti-GDI2 (Proteintech), anti-LAMP1 (Proteintech), anti-FLOT1 (Abways), anti-CD63 (Proteintech), anti-ANGPTL2 (R&D system), anti-ANGPTL3 (R&D system), anti-TPO (Abways), anti-GLUT1 (Proteintech), anti-LDHA (Proteintech), anti-PKM2 (CST), anti-RAB11A (Abways), anti-RAB27A (Abways) and anti-V5 (Biodragon). Fluorescent-conjugated secondary antibodies (Alexa Fluor® 488 or Alexa Fluor® 555) against mouse, rabbit, or goat were obtained from the Thermo Scientific Inc. The details for all the antibodies are listed in Table S3.
    [Show full text]